12:00 AM
 | 
Dec 10, 2012
 |  BC Week In Review  |  Company News  |  Other News

Bend Research, Fraunhofer USA Center for Molecular Biotechnology, PATH, U.S. Department of Defense infectious news

Bend and the not-for-profits said they are using Bend's spray-dried dispersion technology to develop a spray-dried influenza vaccine stable at 50 degrees Celsius for...

Read the full 99 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >